Endocrinology. Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study

By Tulppala Maija   Aho Milla   Tuuri Timo   Vilska Sirpa   Foudila Tuija   Hakala-Ala-Pietilä Tiina   Moilanen Jarna   Bützow Tarja   Kaukoranta Seija   Söderström-Anttila Viveca   Siegberg Rita   Suikkari Anne-Maria  

Human Reproduction, Vol. 14, Iss. 11, 1999-11 ,pp. : 2709-2715

Oxford University Press

Access to resources Recommend Favorite

Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone

By Weston A.M.  

Human Reproduction, Vol. 11, Iss. 3, 1996-03 ,pp. : 608-613

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recombinant follicle stimulating hormone in in-vitro fertilization treatment—clinical experience with follitropin alpha and follitropin beta

By Harlin Jonas   Csemiczky G.   Wramsby H.  

Human Reproduction, Vol. 15, Iss. 2, 2000-02 ,pp. : 239-244

Oxford University Press

Access to resources Recommend Favorite

The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women

By Westergaard Lars G.   Erb Karin   Laursen Steen   Rasmussen Per E.   Rex Sven  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1209-1213

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

By Jansen CAM  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 2995-2999

Oxford University Press

Access to resources Recommend Favorite